iCAD
iCAD offers AI-powered solutions for breast cancer detection, density assessment, and risk evaluation, with a global presence in over 50 countries.
AI-Powered Breast Cancer Detection Solutions
iCAD offers a comprehensive suite of AI-powered solutions designed to improve breast cancer detection, density assessment, and risk evaluation. These advanced technologies aim to enhance the accuracy and efficiency of screening processes, assisting radiologists in making more precise diagnoses. Their notable tool, ProFound AI Risk, utilizes image-based models to evaluate individual risk levels for breast cancer, providing a personalized approach to screening.
ProFound AI Risk Tool
The ProFound AI Risk tool developed by iCAD is an innovative image-based risk model for breast cancer screening. It assesses individual risk by examining specific imaging biomarkers, offering a more tailored evaluation compared to traditional methods. This tool aims to improve early detection and proactive patient care by identifying high-risk individuals who might benefit from more vigilant screening protocols.
Regulatory Approvals and Certifications
iCAD's solutions are recognized for their compliance with various international standards. The tools offered by the company are FDA cleared, CE marked, and Health Canada licensed, ensuring they meet rigorous regulatory requirements across different regions. These certifications underline the credibility and safety of their AI-powered technologies in clinical practice.
Global Presence and Clinical Impact
iCAD has established a strong global presence, with its technology being utilized in over 50 countries around the world. The company has conducted 51 clinical studies and holds 45 patents, showcasing its commitment to advancing AI algorithms in breast cancer detection. Notably, iCAD has trained its AI algorithms on over 6 million images from 100 clinical sites and has analyzed over 40 million mammograms globally in the last five years.
Partnerships and Collaborations
iCAD collaborates with leading industry, research, technology, and advocacy organizations to enhance cancer detection and patient care. These partnerships are pivotal in driving the development of advanced AI solutions and ensuring that patient outcomes continually improve. Collaborating with various stakeholders allows iCAD to stay at the forefront of innovation in medical imaging technologies.